David Shaw’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
David Shaw's JAZZ Position: Q3 2026 in Review
David Shaw reduced its Jazz Pharmaceuticals (JAZZ) stake by 67% in Q3 2026, selling an estimated $14.4M and leaving 28,600 shares worth $6.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2206.
David Shaw first reported a position in JAZZ in Q2 2013 and has held it in 42 quarters since. The position peaked at $56.4M in Q1 2026. 670 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- David Shaw held 28,600 shares of Jazz Pharmaceuticals worth $6.62M as of Q3 2026.
- David Shaw sold 58,475 Jazz Pharmaceuticals shares in Q3 2026, an estimated $14.4M.
- Jazz Pharmaceuticals made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #2206 holding.
- David Shaw first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 42 quarters since.
- David Shaw's Jazz Pharmaceuticals position peaked at $56.4M in Q1 2026.
- 670 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.